Where does Acclarent, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Acclarent, Inc. ranks #1,531 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Acclarent, Inc. hold?

Acclarent, Inc. holds 272 US utility patents granted between 2015 and 2025, spanning 31 technology areas.

What is Acclarent, Inc.'s Innovation Score?

Acclarent, Inc. has an Innovation Score of 54.2 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Acclarent, Inc. focus on?

Acclarent, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 244 patents, ranking #83 of 7,127 assignees active in that subclass. Grants appear in 31 CPC subclasses total.

Is Acclarent, Inc.'s patent grant rate increasing or decreasing?

Acclarent, Inc.'s recent grant velocity is +17% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Acclarent, Inc.'s patents?

Acclarent, Inc.'s patents average 17.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Acclarent, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Acclarent, Inc.

USPTO PatentsView assignee record - 272 granted patents across 31 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Acclarent ranks #1,531 of 49,997 tracked US assignees by granted-patent volume, with 272 patents across 31 technology areas.

#1,531
of 49,997 US assignees by volume: Top 8%
by Innovation Score (54.2/100): 17.6
avg claims per patent: +17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1531 · US Corporation #1,531 · 272 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 272 grants
TOP-DECILE #1,531/49,997
PHOTO-FINISH China University of…
CPC-FOCUS A61B · 31 areas
INNOV-PAR 54.2/100
CLAIMS-RICH 17.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: China University of Mining and Technology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Acclarent’s 54.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 19.4 pts (36%) Velocity 4.6 pts (8%) Breadth 19.7 pts (36%) Claim depth 10.5 pts (19%)

Qualcomm Incorporated · highest

85
Acclarent · this assignee

54
Auto-Kabel Management · near

54
Colder Products · near

54
Lanxess Deutschland · near

54
Solum · near

54
3D Lighting… · lowest

7

What this shows Acclarent's Innovation Score is 54.2/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Acclarent?

Each dot is one of Acclarent’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Acclarent’s own 17.6 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Acclarent vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Acclarent's grants concentrate

Acclarent, Inc. is a focused PatentsView assignee: 31 CPC subclasses with 89.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (37 grants) versus a trough of 17 in 2016. By volume, Acclarent sits between Pearson Education, Inc. and Fairchild Semiconductor Corporation.

Acclarent's three-year grant acceleration

From 2019–2021 to 2022–2024, Acclarent, Inc. moved from 98 to 68 grants (0.69x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,171. See the growth leaderboard.

Pearson Education

273
Roche Sequencing…

273
Valeo Schalter UN…

273
William Marsh Ric…

273
China University…

272
Woodward

272
Acclarent ◀

272
Central Glass

271
Fairchild Semicon…

271

What this shows Acclarent holds 272 patents at rank #1,531, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Acclarent

By rank, the assignees closest to #1,531 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Acclarent's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Acclarent, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Acclarent ranks #83 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Colder Products Company 54 Auto-Kabel Management GmbH 54 Lanxess Deutschland GmbH 54 Solum Co., Ltd. 54

Similar claim depth

Nearest assignees by average claims per patent (17.6 here).

Medtronic Xomed, Inc. 17.6 avg Swimc LLC 17.6 avg SMR Patents S.à.r.l. 17.6 avg McMaster University 17.6 avg

Acclarent's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Acclarent, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	27	9.9%
2016	17	6.3%
2017	23	8.5%
2018	25	9.2%
2019	27	9.9%
2020	37	13.6%
2021	34	12.5%
2022	23	8.5%
2023	24	8.8%
2024	21	7.7%
2025partial year	14	5.1%

Which technologies does Acclarent, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 244

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 209

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 65

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 11

G06T - Image Data Processing OR Generation, IN General 8

G02B - Optical Elements, Systems OR Apparatus 8

G06F - Electric Digital Data Processing 6

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 5

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

G03G - ELECTROGRAPHY; ELECTROPHOTOGRAPHY; Magnetography 3

Y10T - Technical Subjects Covered BY Former US Classification 3

B26D - CUTTING; Details Common TO Machines FOR Perforating, Punching, Cutting-out, Stamping-out OR Severing 2

B62D - Motor VEHICLES; Trailers 2

B21D - Working OR Processing OF Sheet Metal OR Metal Tubes, Rods OR Profiles Without Essentially Removing MATERIAL; Punching Metal 2

Top 15 of 31 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Acclarent, Inc.'s patent record in context - here's where to go next.

Acclarent, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 89.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #1,531 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Acclarent, Inc. against Pearson Education, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 54.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.